|
|
|
|
||
Re: W.L. Interview with Pharmaceutical Executive Magazine on 12/5The P2 data from Willow has been available for a couple of weeks regardless of their saying it will be revealed early next year. If they are "excited" about it they already know they have met or surpassed the threshold set for initiating the P3 trial. This being said it is a game changer with billion dollar plus revenue upside and no other FDA approved competition. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
48878 | Re: W.L. Interview with Pharmaceutical Executive Magazine on 12/5 | walkabout | 0 | 12/12/2019 3:25:53 AM |